We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Phenotypic versus Target-based Screening for Drug Discovery

Article   Apr 24, 2018 | by Joanna Owens, PhD, Freelance Writer and Editor, UK

 
Phenotypic versus Target-based Screening for Drug Discovery
 
 
 

RELATED ARTICLES

Overcoming Challenges in Biopharma: Transformational Innovation is Key

Article

Looking at the industry growth and the complexities of biopharma development, it is no wonder that transformational developments are required to better equip laboratories and operations in biopharma.

READ MORE

Bioengineering and Food Labeling Requirements

Article

In a move aimed to make the origins of food more transparent for consumers, the USDA have launched new rulings regarding the labeling requirements for bioengineered ingredients – but what does this mean for producers, retailers and consumers?

READ MORE

Neutrons – A New Weapon Against Cancer

Article

The development of cancer is a complex process, which can result from minor mistakes in an otherwise well-functioning network of cellular processes. As such, it is essential that scientists have a clear picture of biochemical processes at an atomic level in order to gain an in-depth understanding of how various cancers occur and develop. One technique starting to gain recognition as a powerful tool is neutron crystallography.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE